assessing biosimilars in the real world setting
Published 4 years ago • 5 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
2:45
how real-world data generation can assist biosimilar implementation
-
3:17
practical guidance on the assessment of biosimilar monoclonal antibodies: a pharmacist's perspec...
-
5:20
data requirements for biosimilars
-
4:20
the biosimilar development process
-
14:19
regulatory pathway for biosimilars
-
24:48
fda perspectives on biosimilar bla-manufacturing (28of33) quality – oct. 16-17, 2019
-
3:00
biosimilars: complex copycat drugs
-
18:00
biosimilars part 1: history and biology
-
38:15
biosimilars and biologics
-
57:41
webinar: biologics & biosimilars
-
3:33
biosimilars: manufacturing and inherent variation
-
1:48
dr. markman on the concept of biosimilars in oncology
-
1:36
interchangeable biosimilars
-
11:03
biosimilars in the us and beyond
-
39:16
professor angela thomas: "regulation of biologics & biosimilars"
-
25:07
office of clinical pharmacology (ocp): biosimilars - bioanalysis 2020
-
2:04
biosimilars: the path to approval
-
0:41
similarity of biosimilars and biologics
-
22:48
navigating the world of biosimilar user fees- june 10, 2019
-
25:30
clinical assessment of biosimilars
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
6:18
fda approves of biosimilar to infliximab – ibd in the news